Nanomedicines Based on Recombinant Fusion Proteins for Targeting Therapeutic siRNA Oligonucleotides

Therapeutic Delivery- United Kingdom

doi 10.4155/tde.11.56

Full Text

Abstract

Available in

Date

Authors

Publisher

Future Science Ltd

Related search

Pharmacokinetics and Biodistribution of Recently-Developed siRNA Nanomedicines

Advanced Drug Delivery Reviews
Pharmaceutical Science
2016English

Therapeutic Proteins Derived From Recombinant DNA Technology

International Journal of Current Microbiology and Applied Sciences
2020English

Cancer Nanomedicines Targeting Tumor Extracellular pH

Colloids and Surfaces B: Biointerfaces
SurfacesColloidInterfacesTheoretical ChemistryMedicineBiotechnologySurface ChemistryPhysical
2012English

Development of Pre-Clinical Models for Evaluating the Therapeutic Potential of Candidate siRNA Targeting STAT6

PLoS ONE
Multidisciplinary
2014English

Recombinant Adenoviral Delivery for in Vivo Expression of scFv Antibody Fusion Proteins

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
1998English

Nanomedicines Towards Targeting Intracellular MTB for the Treatment of Tuberculosis

Journal of Interdisciplinary Nanomedicine
2019English

Staphylokinase as a Plasminogen Activator Component in Recombinant Fusion Proteins

Applied and Environmental Microbiology
Applied MicrobiologyBiotechnologyEcologyFood Science
1999English

A Human in Vitro Whole Blood Assay to Predict the Systemic Cytokine Response to Therapeutic Oligonucleotides Including siRNA

PLoS ONE
Multidisciplinary
2013English

Targeting Specific Cells in the Brain With Nanomedicines for CNS Therapies

Journal of Controlled Release
Pharmaceutical Science
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy